Horm Metab Res 1997; 29(3): 145-150
DOI: 10.1055/s-2007-979008
Minisymposium

© Georg Thieme Verlag Stuttgart · New York

Bisphosphonates: Mechanisms of Action and Clinical Use in Osteoporosis - An Update

H. Fleisch
  • Department of Pathophysiology, University of Berne, Berne, Switzerland
Weitere Informationen

Publikationsverlauf

1996

1997

Publikationsdatum:
23. April 2007 (online)

Preview

Bisphosphonates are a new class of compounds with the ability to decrease bone resorption. Their mode of action appears to be complex, involving both a direct effect on the osteoclasts and an indirect one through osteoblasts. They are currently the drugs of choice in humans for Paget's disease and tumor bone disease, and are most useful in various types of osteoporosis. In view of their low toxicity, they are a most valuable addition to our therapeutic possibilities in the treatment of bone diseases.